Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -15.38%-66M | -11.19%-178.48M | -9.85%-57.21M | -57.91%-160.51M | 0.90%-52.08M | 77.29%-101.65M | -31.38%-52.55M | -7,100.69%-447.62M | -23,355.23%-40M | -72.29%6.39M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 65.22%-8K | 36.62%-45K | 41.03%-23K | 15.48%-71K | 44.29%-39K | -37.70%-84K | -1,650.00%-70K | 79.73%-61K | 98.36%-4K | 54.39%-301K |
| Impairment and provisions: | --176K | 38.48%74.92M | ---- | --54.1M | -78.08%583K | ---- | --2.66M | -198.46%-2.88M | ---- | --2.93M |
| -Impairment of property, plant and equipment (reversal) | ---- | 79.97%11.47M | ---- | --6.37M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | --1.91M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | --176K | 3,139.09%42.92M | ---- | --1.33M | -78.08%583K | ---- | --2.66M | -198.46%-2.88M | ---- | --2.93M |
| -Other impairments and provisions | ---- | -53.85%20.53M | ---- | --44.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | 297.58%1.55M | 152.41%785K | -1,002.30%-785K | -33.55%311K | -60.63%87K | 642.86%468K | --221K | --63K | ---- | ---- |
| -Other fair value changes | 297.58%1.55M | 152.41%785K | -1,002.30%-785K | -33.55%311K | -60.63%87K | 642.86%468K | --221K | --63K | ---- | ---- |
| Asset sale loss (gain): | ---- | -113.58%-495K | ---- | --3.64M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -113.58%-495K | ---- | --3.64M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 29.56%8.68M | -10.08%16.66M | -44.16%6.7M | 38.76%18.53M | 88.53%12M | 51.20%13.35M | 79.85%6.37M | 24.95%8.83M | -2.93%3.54M | 32.94%7.07M |
| -Amortization of intangible assets | -37.50%110K | -77.11%1.16M | -93.01%176K | 609.80%5.07M | 10,843.48%2.52M | 4.85%714K | -93.26%23K | -0.15%681K | 0.00%341K | 0.00%682K |
| Financial expense | 4.57%2.26M | -86.68%1.09M | -65.50%2.16M | 306.92%8.17M | 529.19%6.27M | 75.07%2.01M | 212.54%997K | 47.24%1.15M | -8.33%319K | 70.83%779K |
| Special items | -30.27%20.79M | 143.12%35.33M | 506.53%29.82M | 15.79%14.53M | -39.18%4.92M | -97.07%12.55M | -82.41%8.08M | --428.41M | --45.96M | ---- |
| Operating profit before the change of operating capital | -68.37%-32.55M | 18.03%-50.24M | 31.59%-19.33M | 16.44%-61.3M | 17.60%-28.26M | -505.38%-73.35M | -449.25%-34.29M | -171.85%-12.12M | 144.01%9.82M | -43.36%16.87M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 147.99%3.15M | -223.95%-10.23M | -164.38%-6.57M | 135.37%8.25M | 155.99%10.2M | -933.95%-23.33M | -385.79%-18.22M | 118.62%2.8M | -194.81%-3.75M | -123.50%-15.03M |
| Accounts receivable (increase)decrease | -0.28%-8.62M | -203.04%-7.47M | 42.62%-8.6M | -60.87%7.25M | -1,014.28%-14.99M | -7.06%18.52M | -114.34%-1.35M | 0.46%19.92M | 145.06%9.38M | 144.65%19.83M |
| Accounts payable increase (decrease) | 32.85%-4.94M | 140.22%8.9M | -237.82%-7.35M | -194.01%-22.12M | -162.80%-2.18M | 756.06%23.53M | 136.81%3.47M | 88.74%-3.59M | 74.32%-9.41M | -333.53%-31.84M |
| prepayments (increase)decrease | 56.55%11.26M | -123.60%-10.55M | -33.40%7.19M | 211.20%44.71M | -31.32%10.8M | 36.39%-40.21M | 2,499.67%15.73M | -440.75%-63.2M | -66.63%605K | -10,335.71%-11.69M |
| Cash from business operations | 8.54%-31.7M | -199.84%-69.6M | -41.91%-34.65M | 75.53%-23.21M | 29.55%-24.42M | -68.80%-94.84M | -621.94%-34.66M | -157.05%-56.19M | 123.49%6.64M | -178.84%-21.86M |
| Other taxs | ---- | -473.68%-71K | -316.67%-25K | --19K | -101.95%-6K | ---- | 105.97%307K | ---3.76M | -243.03%-5.14M | ---- |
| Net cash from operations | 8.60%-31.7M | -200.39%-69.67M | -41.98%-34.68M | 75.55%-23.19M | 28.90%-24.43M | -58.23%-94.84M | -2,391.86%-34.36M | -174.22%-59.94M | 105.04%1.5M | -54.94%-21.86M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -65.22%8K | -36.62%45K | -41.03%23K | -15.48%71K | -44.29%39K | 37.70%84K | 1,650.00%70K | -79.73%61K | -98.36%4K | -54.39%301K |
| Sale of fixed assets | ---- | --3.51M | --261K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -25.07%-11.57M | 87.82%-13.21M | 81.09%-9.25M | -75.95%-108.49M | -33.64%-48.92M | -564.44%-61.66M | -337.19%-36.61M | -12.98%-9.28M | -258.17%-8.37M | 46.10%-8.21M |
| Purchase of intangible assets | ---- | -159.73%-387K | ---- | 98.12%-149K | ---- | -15,353.85%-7.93M | ---- | --52K | ---- | ---- |
| Recovery of cash from investments | ---- | --17.61M | --17.78M | ---- | ---- | --24.79M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | 95.69%-8.99M | 77.74%-6.7M | ---208.24M | ---30.08M | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 274.38%10.96M |
| Net cash from investment operations | -231.17%-11.56M | 106.97%7.57M | 118.03%8.81M | -102.16%-108.57M | -13.07%-48.89M | 75.30%-53.7M | -12.46%-43.24M | -7,235.12%-217.41M | -533.63%-38.45M | 118.03%3.05M |
| Net cash before financing | -67.24%-43.26M | 52.87%-62.1M | 64.72%-25.87M | 11.30%-131.76M | 5.52%-73.31M | 46.44%-148.55M | -110.01%-77.59M | -1,374.39%-277.35M | -76.78%-36.95M | 39.34%-18.81M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 0.00%10M | -86.49%10M | -84.87%10M | 79.88%74M | 560.97%66.1M | 487.70%41.14M | -76.81%10M | -46.15%7M | 331.21%43.12M | 1.17%13M |
| Refund | 0.00%-10M | 0.00%-10M | 0.00%-10M | -42.86%-10M | -42.86%-10M | 46.15%-7M | 0.00%-7M | -1.17%-13M | 55.84%-7M | ---12.85M |
| Issuing shares | --84.03M | ---- | ---- | -35.37%32.54M | --33M | -87.24%50.35M | ---- | --394.6M | ---- | ---- |
| Interest paid - financing | -4.57%-2.26M | 86.68%-1.09M | 65.50%-2.16M | -306.92%-8.17M | -529.19%-6.27M | -75.07%-2.01M | -212.54%-997K | -47.24%-1.15M | 8.33%-319K | -70.83%-779K |
| Other items of the financing business | ---- | -54.35%25.11M | ---- | --55M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 2,990.44%79.83M | -84.35%21.47M | -103.45%-2.76M | 81.57%137.16M | 5,794.17%80.06M | -80.42%75.54M | -104.01%-1.41M | 15,612.87%385.81M | 587.43%35.1M | -121.68%-2.49M |
| Effect of rate | -58.78%425K | 37.08%122K | -29.43%1.03M | -97.18%89K | 35.40%1.46M | 179.06%3.16M | 2,015.69%1.08M | -2,234.76%-3.99M | 920.00%51K | 334.88%187K |
| Net Cash | 227.77%36.58M | -851.85%-40.63M | -524.10%-28.63M | 107.40%5.4M | 108.54%6.75M | -167.31%-73M | -4,177.04%-79M | 609.24%108.46M | 93.43%-1.85M | -9.02%-21.3M |
| Begining period cash | -82.19%8.78M | 12.54%49.29M | 12.54%49.29M | -61.46%43.79M | -61.46%43.79M | 1,138.72%113.64M | 1,138.72%113.64M | -69.71%9.17M | -69.71%9.17M | -39.16%30.29M |
| Cash at the end | 111.06%45.78M | -82.19%8.78M | -58.29%21.69M | 12.54%49.29M | 45.58%52.01M | -61.46%43.79M | 384.17%35.72M | 1,138.72%113.64M | 237.05%7.38M | -69.71%9.17M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.